| View |
|
DRP-5966-15
|
Co-Amoxiclav
|
Trinmoxil
|
457 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Combination of penicillin and beta-lactamase inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
24 April 2024
|
27 January 2030
|
| View |
|
DRP-5966-21
|
Co-Amoxiclav
|
Clovoxclav-457
|
457 mg/5 mL
|
Powder for Suspension
|
Antibacterial
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
29 April 2024
|
27 January 2030
|
| View |
|
DRP-5966-24
|
Co-Amoxiclav
|
Clavzivac
|
457 mg/ 5mL
|
Powder for Suspension
|
Antibacterial
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
26 April 2024
|
27 January 2030
|
| View |
|
DRP-6339-05
|
Atorvastatin (as calcium)
|
Atorpel
|
40 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
25 April 2024
|
11 September 2025
|
| View |
|
DRP-6340-05
|
Atorvastatin (as calcium)
|
Atorpel
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
24 April 2024
|
11 September 2025
|
| View |
|
DRP-6540-04
|
Atorvastatin (as Calcium)
|
Carvast
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Hizon Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
30 April 2024
|
08 July 2029
|
| View |
|
DRP-6601-14
|
Folic Acid
|
Nufolac
|
5 mg
|
Capsule
|
Anti-anemic
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
28 April 2024
|
28 January 2025
|
| View |
|
DRP-6779-06
|
Ceftriaxone (as Sodium)
|
Gifixon
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
AJU PHARM CO., LTD.
|
Korea
|
CLIDP Conversion
|
26 April 2024
|
15 April 2029
|
| View |
|
DRP-6790-08
|
Multivitamins + Dextrose
|
Multiden
|
(see reverse page for formulation)
|
Solution for Injection (I.V. Infusion)
|
Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical
|
China
|
CLIDP Conversion
|
25 April 2024
|
07 November 2028
|
| View |
|
DRP-7056-01
|
Atorvastatin (as Calcium)
|
None
|
20mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
15 April 2024
|
02 October 2027
|
| View |
|
DRP-7129-06
|
Sitagliptin (as phosphate monohydrate)
|
None
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
25 April 2024
|
20 April 2026
|
| View |
|
DRP-7202-02
|
Risperidone
|
Risperkip
|
2 mg
|
Film Coated Tablet
|
Anti-Psychotic ( other antipsychotics )
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
27 April 2024
|
06 November 2027
|
| View |
|
DRP-7270-02
|
Levothyroxine (as sodium)
|
Levothyrogen
|
50 mcg
|
Tablet
|
Thyroid Hormone Replacement
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
07 April 2024
|
30 July 2029
|
| View |
|
DRP-7317-05
|
Cefuroxime (as Axetil)
|
Mediroxime
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Second Generation Cephalosporin)
|
Sance Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 April 2024
|
11 September 2027
|
| View |
|
DRP-7356-09
|
Cefixime (as trihydrate)
|
Protexime 200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 April 2024
|
21 February 2029
|
| View |
|
DRP-7357-08
|
Cefixime (as trihydrate)
|
Protexime 400
|
400 mg
|
Dispersible Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 April 2024
|
26 February 2029
|
| View |
|
DRP-7699-02
|
Zinc
|
Kalista
|
20 mg/ 5 mL (equivalent to 55 mg Zinc Sulfate monohydrate)
|
Syrup
|
Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 April 2024
|
06 June 2028
|
| View |
|
DRP-7734-08
|
Dexamethasone + Neomycin (as sulfate) + Polymyxin-B-Sulfate
|
Poneda
|
1 mg / 3.5mg/6000 IU
|
Ophthalmic & Otic Solution
|
Corticosteroid/ Anti-Infective
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
10 April 2024
|
16 March 2028
|
| View |
|
DRP-7829-02
|
Ketorolac trometamol
|
None
|
30mg/mL
|
Solution for Injection
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Aju Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
27 April 2024
|
16 April 2028
|
| View |
|
DRP-8044-05
|
Tobramycin
|
Tobracor
|
3 mg / mL (0.3 % w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
09 April 2024
|
05 December 2028
|